SCHEMBL6608119

SCHEMBL6608119

CN(c1cc(NC(=O)O)c(N)cc1Cl)C1CC1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
HSD11B1 P28845 6/20 0.34
POLB P06746 1/20 0.33
ATM Q13315 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
S1PR1 P21453 1/20 0.32
GPR35 Q9HC97 1/20 0.32
IDO1 P14902 1/20 0.32
ALDH1A1 P00352 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
PTPN11 Q06124 1/20 0.31
ROCK2 O75116 1/20 0.31
MAPT P10636 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
ABCC1 P33527 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6165850 0.83 AAK1 (0.39)
SCHEMBL6610509 0.83 GAA (0.37) NPC1L3MBTL1GPR35ALDH1A1KMT2A
SCHEMBL6607347 0.82 CFTR (0.34) IDO1
SCHEMBL6641220 0.80 MAPT (0.40) NPC1RAB9AALDH1A1MAPTNPSR1
SCHEMBL27597110 0.78 ALDH1A1 (0.33) GPR35ALDH1A1MEN1KMT2A
SCHEMBL27597109 0.75 PTGS2 (0.44) RAB9AIDO1ALDH1A1MEN1KMT2A
SCHEMBL6610270 0.73 HDAC2 (0.38) RAB9AALDH1A1MEN1KMT2A
SCHEMBL27597105 0.73 CD44 (0.52) NPC1RAB9AL3MBTL1GPR35ALDH1A1
SCHEMBL27597171 0.70 CD44 (0.52) NPC1RAB9AL3MBTL1GPR35ALDH1A1
SCHEMBL6608117 0.69 PTGER4 (0.47) NPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1379511-A1 DIHYDRO-BENZO (b) (1, 4) DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II F. HOFFMANN-LA ROCHE AG (CH) 2004-01-14 EP disclosed
WO-2002083652-A1 DIHYDRO-BENZO [b] [1, 4] DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II F. HOFFMANN-LA ROCHE AG (CH) 2002-10-24 WO disclosed